Adherence to Antimalarial Therapy Reduces Risk for Type 2 Diabetes in SLE
Adherence to antimalarial therapy can provide a protective effect against the development of type 2 diabetes in patients with systemic lupus erythematosus.
Lupus
Increased S aureus Colonization in Skin Lesions Among Patients With Lupus
Patients with systemic lupus erythematosus (SLE) have increased colonization with Staphylococcus aureus in cutaneous lupus erythematosus lesions.
Renal Arteriosclerosis Common But Underreported in Lupus Nephritis
Researchers examined the burden of renal arteriosclerosis in lupus nephritis (LN), and they also assessed whether arteriosclerosis was underreported in LN biopsies.
Chronic Damage Not Affected by Pregnancy in Systemic Lupus Erythematosus
Researchers evaluated the chronic damage associated with pregnancies before and after the diagnosis of systemic lupus erythematosus.
Anti-Carbamylated Protein Antibodies Linked to SLE Disease Activity
Researchers evaluated levels of serum anti-carbamylated protein antibodies and assessed their clinical value in systemic lupus erythematosus.
Neuropsychiatric Events Most Frequently Occur at SLE Diagnosis
Researchers examined the association between neuropsychiatric events and health-related quality of life in a cohort of patients with systemic lupus erythematosus.
Visual Analog Scale Assessments Can Reliably Assess Disease Severity in SLE
Researchers compared the performance of 2 visual analog scale-based assessments, SSPGA and LFA-REAL, with outcome measures from other lupus trials.
Renal Arteriosclerosis Develops Prematurely in Lupus Nephritis
A study found that renal arteriosclerosis develops 2 decades earlier in patients with lupus nephritis compared with healthy age-matched controls.
Peripheral Nervous System Disease Has Significant Negative Effect on Quality of Life in SLE
Peripheral nervous system (PNS) disease is a component of systemic lupus erythematosus (SLE) disease activity and has a significant negative impact on health-related quality of life.
Antimalarial Drugs May Reduce Polyautoimmunity in Systemic Lupus Erythematosus
Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
Next post in Systemic Lupus Erythematosus
